Category Specific RSS

Neuren Pharmaceuticals

Neurotech applies for ethics approval to trial cannabis as a treatment for Rett Syndrome

About one in 9,000 females in Australia are diagnosed with Rett Syndrome at birth. In the US, about 15,000 girls…

2 years ago

Pharmaxis welcomes leading medical researcher and healthcare investment guru as Director

As a medical research company, successful trial outcomes are a must but business acumen in understanding the market is no…

3 years ago

Neuren Pharmaceuticals gains approval for trial in yet another neurodevelopmental disorder

The complexity of the human body never ceases to amaze me. So many systems need to work together to carry…

3 years ago

Neuren secures European patent for drug aimed to treat incurable brain disorders

Australian biopharmaceuticals developer Neuren Pharmaceuticals (ASX: NEU) has been granted a patent from the European Patent Office covering NNZ-2591, a…

6 years ago